Search research articles
Contact Us
Filters
Showing results (161-170 of 239) with videos related to
Page
of 24
Sort By:
Journal of Cellular Physiology
|
March 10, 2007
Adenosine receptors in colon carcinoma tissues and colon tumoral cell lines: focus on the A(3) adenosine subtype
Stefania Gessi, Stefania Merighi, Katia Varani, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
September 6, 2003
Aberrant A2A receptor function in peripheral blood cells in Huntington's disease
Katia Varani, Maria P Abbracchio, Milena Cannella, et al.
Journal of Medicinal Chemistry
|
July 8, 2005
New pyrrolo[2,1-f]purine-2,4-dione and imidazo[2,1-f]purine-2,4-dione derivatives as potent and selective human A3 adenosine receptor antagonists
Pier Giovanni Baraldi, Delia Preti, Mojgan Aghazadeh Tabrizi, et al.
Journal of Medicinal Chemistry
|
July 22, 2005
New 2-arylpyrazolo[4,3-c]quinoline derivatives as potent and selective human A3 adenosine receptor antagonists
Pier Giovanni Baraldi, Mojgan Aghazadeh Tabrizi, Delia Preti, et al.
Journal of Pineal Research
|
April 12, 2024
Binding and unbinding of potent melatonin receptor ligands: Mechanistic simulations and experimental evidence
Annalida Bedini, Gian Marco Elisi, Fabiola Fanini, et al.
Bioorganic & Medicinal Chemistry
|
December 14, 2007
1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists
Mojgan Aghazadeh Tabrizi, Pier Giovanni Baraldi, Delia Preti, et al.
Bioorganic & Medicinal Chemistry
|
May 26, 2009
6-Amino-2-mercapto-3H-pyrimidin-4-one derivatives as new candidates for the antagonism at the P2Y12 receptors
Pamela Crepaldi, Barbara Cacciari, Maria-Cruz Bonache, et al.
European Journal of Medicinal Chemistry
|
February 29, 2016
Synthesis and structure activity relationship investigation of triazolo[1,5-a]pyrimidines as CB2 cannabinoid receptor inverse agonists
Mojgan Aghazadeh Tabrizi, Pier Giovanni Baraldi, Emanuela Ruggiero, et al.
Journal of Medicinal Chemistry
|
September 12, 2009
2-Phenylpyrazolo[4,3-d]pyrimidin-7-one as a new scaffold to obtain potent and selective human A3 adenosine receptor antagonists: new insights into the receptor-antagonist recognition
Ombretta Lenzi, Vittoria Colotta, Daniela Catarzi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
January 25, 2017
The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A<sub>1</sub> and A<sub>2A</sub> receptor affinity and selectivity profiles
Lucia Squarcialupi, Marco Betti, Daniela Catarzi, et al.
Page
of 24
Search research articles
Search
Showing results (161-170 of 239) with videos related to
Sort By:
Page
of 24
Journal of Cellular Physiology
|
March 10, 2007
Adenosine receptors in colon carcinoma tissues and colon tumoral cell lines: focus on the A(3) adenosine subtype
Stefania Gessi, Stefania Merighi, Katia Varani, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
September 6, 2003
Aberrant A2A receptor function in peripheral blood cells in Huntington's disease
Katia Varani, Maria P Abbracchio, Milena Cannella, et al.
Journal of Medicinal Chemistry
|
July 8, 2005
New pyrrolo[2,1-f]purine-2,4-dione and imidazo[2,1-f]purine-2,4-dione derivatives as potent and selective human A3 adenosine receptor antagonists
Pier Giovanni Baraldi, Delia Preti, Mojgan Aghazadeh Tabrizi, et al.
Journal of Medicinal Chemistry
|
July 22, 2005
New 2-arylpyrazolo[4,3-c]quinoline derivatives as potent and selective human A3 adenosine receptor antagonists
Pier Giovanni Baraldi, Mojgan Aghazadeh Tabrizi, Delia Preti, et al.
Journal of Pineal Research
|
April 12, 2024
Binding and unbinding of potent melatonin receptor ligands: Mechanistic simulations and experimental evidence
Annalida Bedini, Gian Marco Elisi, Fabiola Fanini, et al.
Bioorganic & Medicinal Chemistry
|
December 14, 2007
1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists
Mojgan Aghazadeh Tabrizi, Pier Giovanni Baraldi, Delia Preti, et al.
Bioorganic & Medicinal Chemistry
|
May 26, 2009
6-Amino-2-mercapto-3H-pyrimidin-4-one derivatives as new candidates for the antagonism at the P2Y12 receptors
Pamela Crepaldi, Barbara Cacciari, Maria-Cruz Bonache, et al.
European Journal of Medicinal Chemistry
|
February 29, 2016
Synthesis and structure activity relationship investigation of triazolo[1,5-a]pyrimidines as CB2 cannabinoid receptor inverse agonists
Mojgan Aghazadeh Tabrizi, Pier Giovanni Baraldi, Emanuela Ruggiero, et al.
Journal of Medicinal Chemistry
|
September 12, 2009
2-Phenylpyrazolo[4,3-d]pyrimidin-7-one as a new scaffold to obtain potent and selective human A3 adenosine receptor antagonists: new insights into the receptor-antagonist recognition
Ombretta Lenzi, Vittoria Colotta, Daniela Catarzi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
January 25, 2017
The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A<sub>1</sub> and A<sub>2A</sub> receptor affinity and selectivity profiles
Lucia Squarcialupi, Marco Betti, Daniela Catarzi, et al.
Page
of 24